Submitted by Anonymous (not verified) on 19 September 2024 - 14:10
Opinion/decision on a Paediatric investigation plan (PIP): Relvar Ellipta, vilanterol,fluticasone furoate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0092/2021
Source: